Search results
The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research and review articles, and editorial opinion on a wide variety of topics...
- Image Challenge
Image Challenge from the New England Journal of Medicine —...
- Specialties
Featuring articles on topics such as leukemia, breast...
- Topics
LOOKING FOR SPECIALTIES? VIEW SPECIALTIES. ARTICLE...
- Multimedia
T. Facon and Others N Engl J Med 2024;391:1597-1609. Summary...
- Current Issue
More on Type 2 Diabetes in Patients with G6PD Deficiency....
- Learning/CME
CME activities, cases, challenges, videos, and more teaching...
- Author Center
Welcome. Thank you for considering the New England Journal...
- Allergy Immunology
C.N. Duncan and Others N Engl J Med 2024;391:1287-1301...
- Image Challenge
Fundamentals of Medical Ethics. Gray Matters. Health Policy. Medicine and Society. Nutrition in Medicine. Race and Medicine. Recognizing Historical Injustices and the Journal. View All Topics...
More on Type 2 Diabetes in Patients with G6PD Deficiency. Explore the current issue of The New England Journal of Medicine (Vol. 391 No. 17).
2 kwi 2022 · In pregnant women with mild chronic hypertension, a strategy of targeting a blood pressure of less than 140/90 mm Hg was associated with better pregnancy outcomes than a strategy of reserving treatment only for severe hypertension, with no increase in the risk of small-for-gestational-age birth weig ….
10 lut 2023 · Methods: We performed a prospective, randomized, open-label, adaptive, international trial involving patients with stroke due to occlusion of the internal carotid artery or the first segment of the middle cerebral artery to assess endovascular thrombectomy within 24 hours after onset.
3 sie 2017 · The addition of the multitargeted kinase inhibitor midostaurin to standard chemotherapy significantly prolonged overall and event-free survival among patients with AML and a FLT3 mutation. (Funded by the National Cancer Institute and Novartis; ClinicalTrials.gov number, NCT00651261 .).
14 cze 2024 · Intravenous tenecteplase has been shown to be noninferior to alteplase, with a meta-analysis suggesting superiority, 1 and although tenecteplase has been used off label, it is replacing alteplase...
